Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT
- 12 February 2021
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 62 (10), 1415-1421
- https://doi.org/10.2967/jnumed.120.257279
Abstract
Positron emission tomography/computed tomography (PET/CT) with 18F-fluorodesoxyglucose (FDG) is an integral component in the primary staging of most lymphomas. However, its utility is limited in marginal zone lymphoma (MZL) due to inconsistent FDG avidity. One diagnostic alternative could be the targeting of CXC-motif chemokine receptor 4 (CXCR4), shown to be expressed by MZL cells. This study investigated the value of adding CXCR4-directed 68Ga-Pentixafor PET/CT to conventional staging. Methods: 22 newly diagnosed MZL patients were staged conventionally and with 68Ga-Pentixafor PET/CT. Lesions exclusively identified by 68Ga-Pentixafor PET/CT were biopsied as standard of reference and compared to imaging results. The impact of CXCR4-directed imaging on staging results and treatment protocol was assessed. Results: 68Ga-Pentixafor PET/CT correctly identified all patients with viable MZL and was superior to conventional staging (P < 0.001). CXCR4-directed imaging results were validated by confirmation of MZL in 21/24 PET-guided biopsy samples. Inclusion of 68Ga-Pentixafor PET/CT in primary staging significantly impacted staging results in almost half, and treatment protocols in one third of patients (upstaging, n = 7; downstaging, n = 3; treatment change, n = 8; P < 0.03). Conclusion: 68Ga-Pentixafor PET/CT is a suitable tool in primary staging of MZL and holds the potential to improve existing diagnostic algorithms.This publication has 22 references indexed in Scilit:
- 68Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in GlioblastomaTheranostics, 2016
- In vivo molecular imaging of chemokine receptor CXCR 4 expression in patients with advanced multiple myelomaEMBO Molecular Medicine, 2015
- Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular ImagingTheranostics, 2015
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano ClassificationJournal of Clinical Oncology, 2014
- Detection rate of fluorine‐18‐fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta‐analysisHematological Oncology, 2014
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and ImmunityAnnual Review of Immunology, 2014
- Cationic eluate pretreatment for automated synthesis of [68Ga]CPCR4.2Nuclear Medicine and Biology, 2014
- Homeostatic chemokine receptors and organ-specific metastasisNature Reviews Immunology, 2011
- Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomasBlood, 2004
- 18F-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG-PET) for Staging and Follow-Up of Marginal Zone B-Cell LymphomaOncology, 2003